These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38824765)

  • 1. Metabolic features of adolescent major depressive disorder: A comparative study between treatment-resistant depression and first-episode drug-naive depression.
    Gan X; Li X; Cai Y; Yin B; Pan Q; Teng T; He Y; Tang H; Wang T; Li J; Zhu Z; Zhou X; Li J
    Psychoneuroendocrinology; 2024 Sep; 167():107086. PubMed ID: 38824765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of polyamine pathway to determinations of diagnosis for treatment-resistant depression: A metabolomic analysis.
    You Z; Wang C; Lan X; Li W; Shang D; Zhang F; Ye Y; Liu H; Zhou Y; Ning Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110849. PubMed ID: 37659714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulations of amino acid metabolism and lipid metabolism in urine of children and adolescents with major depressive disorder: a case-control study.
    Jiang Y; Cai Y; Teng T; Wang X; Yin B; Li X; Yu Y; Liu X; Wang J; Wu H; He Y; Zhu ZJ; Zhou X
    Psychopharmacology (Berl); 2024 Aug; 241(8):1691-1703. PubMed ID: 38605232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel.
    Sharman Moser S; Chodick G; Gelerstein S; Barit Ben David N; Shalev V; Stein-Reisner O
    BMC Psychiatry; 2022 Aug; 22(1):541. PubMed ID: 35948895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive analysis of the economic burden of treatment resistance in a major depressive episode.
    Cai Q; Sheehan JJ; Wu B; Alphs L; Connolly N; Benson C
    Curr Med Res Opin; 2020 Feb; 36(2):329-335. PubMed ID: 31540559
    [No Abstract]   [Full Text] [Related]  

  • 7. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.
    Yin B; Cai Y; Teng T; Wang X; Liu X; Li X; Wang J; Wu H; He Y; Ren F; Kou T; Zhu ZJ; Zhou X
    Transl Psychiatry; 2024 Mar; 14(1):163. PubMed ID: 38531835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
    Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
    JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression.
    Wu B; Cai Q; Sheehan JJ; Benson C; Connolly N; Alphs L
    PLoS One; 2019; 14(8):e0220763. PubMed ID: 31393922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis.
    Perugi G; Pacchiarotti I; Mainardi C; Verdolini N; Menculini G; Barbuti M; Angst J; Azorin JM; Bowden CL; Mosolov S; Young AH; Vieta E;
    Eur Neuropsychopharmacol; 2019 Jul; 29(7):825-834. PubMed ID: 31227264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
    Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
    Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics-based discrimination of patients with remitted depression from healthy controls using
    Hung CI; Lin G; Chiang MH; Chiu CY
    Sci Rep; 2021 Aug; 11(1):15608. PubMed ID: 34341439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents.
    Zhou X; Liu L; Lan X; Cohen D; Zhang Y; Ravindran AV; Yuan S; Zheng P; Coghill D; Yang L; Hetrick SE; Jiang X; Benoliel JJ; Cipriani A; Xie P
    Mol Psychiatry; 2019 Oct; 24(10):1478-1488. PubMed ID: 29679072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency-specific alterations in functional connectivity in treatment-resistant and -sensitive major depressive disorder.
    He Z; Cui Q; Zheng J; Duan X; Pang Y; Gao Q; Han S; Long Z; Wang Y; Li J; Wang X; Zhao J; Chen H
    J Psychiatr Res; 2016 Nov; 82():30-9. PubMed ID: 27459030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.
    Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
    Addiction; 2019 Jul; 114(7):1274-1282. PubMed ID: 30938020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant resistance in adolescents with major depressive disorder: A nationwide longitudinal study.
    Chen LC; Chen YH; Bai YM; Chen TJ; Chen MH; Su TP
    J Affect Disord; 2020 Feb; 262():293-297. PubMed ID: 31733920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular serum signature of treatment resistant depression.
    Ruland T; Chan MK; Stocki P; Grosse L; Rothermundt M; Cooper JD; Arolt V; Bahn S
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):3051-9. PubMed ID: 27325393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and economic burden of treatment-resistant depression in Thailand.
    Prasartpornsirichoke J; Pityaratstian N; Poolvoralaks C; Sirinimnualkul N; Ormtavesub T; Hiranwattana N; Phonsit S; Rungnirundorn T
    BMC Public Health; 2023 Aug; 23(1):1541. PubMed ID: 37573321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic risk scores of lithium response and treatment resistance in major depressive disorder.
    Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Sigström R; Jonsson L; Clements CC; Andersson E; Boberg J; Lewis CM; Sullivan PF; Landén M; Lu Y
    Transl Psychiatry; 2023 Sep; 13(1):301. PubMed ID: 37770441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Evaluation of the Clinical and Economic Burden Among Older Adult Medicare-Covered Beneficiaries With Treatment-Resistant Depression.
    Benson C; Szukis H; Sheehan JJ; Alphs L; Yuce H
    Am J Geriatr Psychiatry; 2020 Mar; 28(3):350-362. PubMed ID: 31735488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.